14 Current news of Illumina
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
11-Aug-2006
Genizon BioSciences has become the first commercial organization to achieve certification under the new Certified Service Provider (CSPro) Program from Illumina, Inc. This certification assures compliance with the highest quality standards for Genizon's new genotyping services. The Illumina ...
24-Jul-2006
Illumina, Inc. and ReaMetrix, Inc. announced the formation of a diagnostic collaboration under which the companies plan to co-develop molecular diagnostic panels for a range of disease areas. Under the terms of the agreement, ReaMetrix will gain non-exclusive rights to market the resulting panels ...
Companies to initiate work on molecular diagnostics for the risk of heart attack, type 2 diabetes and breast cancer
17-May-2006
deCODE genetics and Illumina, Inc. announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major disease areas. The alliance will employ Illumina's platform for high-multiplex single-nucleotide ...
Illumina to Gain Exclusive, Licensed Access to Biomarkers Discovered Through Disease Studies
27-Oct-2005
Illumina, Inc. announced an agreement of sale with PharmacoDesign (PD) for a BeadStation system and whole-genome genotyping arrays and reagents for ongoing pharmacogenomics studies. PharmacoDesign will genotype various Korean populations with the aim of understanding genetic variation and ...
